Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences.

Benoit SC, Schwartz MW, Lachey JL, Hagan MM, Rushing PA, Blake KA, Yagaloff KA, Kurylko G, Franco L, Danhoo W, Seeley RJ.

J Neurosci. 2000 May 1;20(9):3442-8.

2.

Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues.

Marsh DJ, Miura GI, Yagaloff KA, Schwartz MW, Barsh GS, Palmiter RD.

Brain Res. 1999 Nov 27;848(1-2):66-77.

PMID:
10612698
3.

Melanocortin-4 receptor: a novel signalling pathway involved in body weight regulation.

Fisher SL, Yagaloff KA, Burn P.

Int J Obes Relat Metab Disord. 1999 Feb;23 Suppl 1:54-8. Review.

PMID:
10193863
4.

Identification and functional analysis of novel human melanocortin-4 receptor variants.

Gu W, Tu Z, Kleyn PW, Kissebah A, Duprat L, Lee J, Chin W, Maruti S, Deng N, Fisher SL, Franco LS, Burn P, Yagaloff KA, Nathan J, Heymsfield S, Albu J, Pi-Sunyer FX, Allison DB.

Diabetes. 1999 Mar;48(3):635-9.

PMID:
10078568
5.

Melanocortin and leptin signaling systems: central regulation of catabolic energy balance.

Fisher SL, Yagaloff KA, Burn P.

J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):203-16. Review.

PMID:
10071759
6.

Role of the CNS melanocortin system in the response to overfeeding.

Hagan MM, Rushing PA, Schwartz MW, Yagaloff KA, Burn P, Woods SC, Seeley RJ.

J Neurosci. 1999 Mar 15;19(6):2362-7.

7.

Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.

Marsh DJ, Hollopeter G, Huszar D, Laufer R, Yagaloff KA, Fisher SL, Burn P, Palmiter RD.

Nat Genet. 1999 Jan;21(1):119-22.

PMID:
9916804
8.

The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling.

Zeng W, Xu X, Popov S, Mukhopadhyay S, Chidiac P, Swistok J, Danho W, Yagaloff KA, Fisher SL, Ross EM, Muallem S, Wilkie TM.

J Biol Chem. 1998 Dec 25;273(52):34687-90.

9.

Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion.

Thiele TE, van Dijk G, Yagaloff KA, Fisher SL, Schwartz M, Burn P, Seeley RJ.

Am J Physiol. 1998 Jan;274(1 Pt 2):R248-54.

PMID:
9458925
10.

Melanocortin receptors in leptin effects.

Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, Schwartz MW.

Nature. 1997 Nov 27;390(6658):349. No abstract available.

PMID:
9389472
11.

Induction of c-fos in mouse bone marrow macrophages: a direct method for assessing bone marrow cell activation.

Yagaloff KA, Xie F.

Biochem Biophys Res Commun. 1995 Jun 26;211(3):767-73.

PMID:
7598705
12.

Essential fatty acids are antagonists of the leukotriene B4 receptor.

Yagaloff KA, Franco L, Simko B, Burghardt B.

Prostaglandins Leukot Essent Fatty Acids. 1995 May;52(5):293-7.

PMID:
7630916
13.

Insulin receptor signaling. Activation of multiple serine kinases.

Czech MP, Klarlund JK, Yagaloff KA, Bradford AP, Lewis RE.

J Biol Chem. 1988 Aug 15;263(23):11017-20. Review. No abstract available.

14.

Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex.

Blue ME, Yagaloff KA, Mamounas LA, Hartig PR, Molliver ME.

Brain Res. 1988 Jun 21;453(1-2):315-28.

PMID:
3401769
15.
16.

Serotonin 5-HT1C receptors are expressed at high density on choroid plexus tumors from transgenic mice.

Yagaloff KA, Lozano G, van Dyke T, Levine AJ, Hartig PR.

Brain Res. 1986 Oct 22;385(2):389-94.

PMID:
3022874
17.

Solubilization and characterization of the serotonin 5-HT1c site from pig choroid plexus.

Yagaloff KA, Hartig PR.

Mol Pharmacol. 1986 Feb;29(2):120-5.

PMID:
3951427
18.

Supplemental Content

Loading ...
Support Center